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Abstract: Infertility is an important health problem that affects up to 16% of couples worldwide.
Male infertility is responsible for 50% of the cases. Currently, a physical examination, hormone
profiling and the evaluation of two consecutive semen samples (to determine the sperm concentration,
motility, morphology and, in very few cases, sperm DNA integrity) are the sole tools that physicians
have to evaluate infertility in men. Antioxidant therapy is often used to improve sperm quality and
function in infertile men. However, there are controversial results regarding the efficacy of these
treatments. Prdx6−/− male mice are subfertile, displaying significant oxidative damage in the lipids,
proteins and DNA of their spermatozoa. Here, we used Prdx6−/− male mice to test whether a novel
combination of tocopherols that contained 60% γ-tocopherol and ascorbic acid could restore their
fertility. These mice were fed with the supplemented (Vit. Mix) or control diets. To assess sperm
quality, we determined the motility, levels of lipid peroxidation, DNA oxidation and tyrosine nitration
in the spermatozoa. The number of pups sired by the Prdx6−/− mice fed with the Vit. Mix diet was
higher than that sired by the males fed with the control diet, and the pups’ mortality was lower.
The sperm quality was improved in the males fed with the supplemented diet. We concluded that
treatment with a supplement composed of tocopherols and rich in γ-tocopherol and ascorbic acid is
effective in restoring fertility in cases where oxidative stress and high levels of tyrosine nitration are
associated with male infertility.
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1. Introduction
Male infertility is of great medical issue in humans because approximately 16% of couples
worldwide are affected by infertility, and in 50% of these cases, the causes can be ascribed to the man [1].
Environmental pollutants, chemicals, drugs, smoke, toxins, radiation and diseases that have adverse
effects on fertility have in common oxidative stress [2–6]. The presence of high levels of reactive oxygen
species (ROS) in semen has been reported in 25–87% of infertile patients [7–9].
Male idiopathic infertility has a prevalence of 23% [10]. We found that patients with idiopathic
infertility had reduced amounts of peroxiredoxin 6 (PRDX6) in spermatozoa compared to healthy
donors [11]. Of note, thiol-oxidized PRDX6 (inactive) levels and the presence of high molecular mass
complexes (containing the inactive PRDX6-SO2) [12] are present in the spermatozoa in 90% of idiopathic
infertile men [11]. Due to the reduced amounts of the PRDX6 protein and its oxidation status, very little
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antioxidant protection (less than 20%) remains in the spermatozoa. This reduced antioxidant protection
could be a possible cause of the impairment of sperm function and poor DNA quality observed in
these patients [11].
Our studies demonstrated that human spermatozoa displayed higher levels of DNA oxidation
when treated with specific inhibitors of PRDX6 calcium-independent phospholipase A2 (iPLA2) activity
(1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol lithium (MJ33)) than the non-treated
controls or sperm incubated with inhibitors of PRDX1–5 (conoidin A), thioredoxin reductase (TRD;
auranofin) or GSTπ (ezatiostat), or in which GSH was depleted with ethacrynic acid [13]. By establishing
dose–response curves, we determined which concentrations of these inhibitors were toxic by assessing
sperm viability by flow cytometry using calcein-AM and found that human spermatozoa are more
sensitive to the inhibition of PRDX6 iPLA2 (with MJ33) than that of 2-Cys PRDXs (with conoidin A) [13].
Moreover, the toxic lipid peroxidation product 4-hydroxynonenal (4-HNE) was significantly increased
by the treatment with MJ33 but not with conoidin A, suggesting that it is the PRDX6 iPLA2
activity that protects spermatozoa against lipid peroxidation [13]. This protection solely by PRDX6 is
important because 4-HNE is mutagenic and responsible for damage to DNA [14]. We also found that
PRDX6 peroxidase activity alone protects the spermatozoon against increased levels of peroxynitrite
(ONOO–) [13]. Because ONOO− induces lipid peroxidation [15], PRDX6, through its two enzymatic
activities, is the protector of the paternal genome against lipid peroxidation. Altogether, these findings
strongly suggest an essential role of PRDX6 in the protection of human spermatozoa against oxidative
stress and offer a possible cause for the impaired sperm function in idiopathic infertile patients.
Prdx6−/− male mice are subfertile; they produce 50% fewer viable pups than wild-type males and
show sperm of low quality with low motility and significant oxidative damage [16]. We previously
demonstrated that fertilization rates were reduced by 80% when using Prdx6−/− compared to wild type
(WT) spermatozoa, and Prdx6−/− spermatozoa were unable to produce blastocysts (pre-implantation
embryos) in vitro [17]. Because of the poor reproductive performance of Prdx6−/− males under in vivo
and in vitro conditions, this model is ideal for studying how ROS affect male fertility and the search
for a successful treatment.
Antioxidant therapy is a common clinical strategy for improving sperm quality and function
in infertile men. There are controversial results regarding the efficacy of these treatments [9]. In the
particular case of treatment with vitamins E and C, there are controversial data supporting the beneficial
effect on the achievement of live births [9,18]. Tocopherols (the active form of vitamin E) scavenge
ROS, and ascorbic acid converts the tocopheryl radicals (oxidized tocopherol generated by ROS) [19]
to tocopherol for the re-cycling of vitamin E. As mentioned above, PRDX6 peroxidase activity is the
unique scavenger of ONOO– in human spermatozoa [13]. Although both α- and γ-tocopherol can
scavenge H2O2 and organic peroxides, γ-tocopherol is a more efficient scavenger of ONOO– and of
lipophilic electrophiles capable of inducing lipid peroxidation than α-tocopherol [15,20,21], the most
commonly used vitamin E form in antioxidant supplement preparations.
Here, we used Prdx6−/− male mice to determine whether dietary supplementation with a
combination of tocopherols rich in γ-tocopherol and ascorbic acid restored their fertility.
2. Materials and Methods
2.1. Animals and Dietary Treatment
Wild type (WT, C57Bl6/J) and Prdx6−/− male mice were produced from our colonies at the Research
Institute, McGill University Health Centre (Montreal, QC, Canada). The C57Bl6/J breeder pairs were
purchased from Charles River (Laval, QC, Canada). The Prdx6−/− mouse model was generated by
Dr. Y. Ho in collaboration with Dr. A. Fisher at the University of Pennsylvania (Philadelphia, PA,
USA) [22,23]. The mice were maintained on a 14L/10D cycle. Food and water were provided ad libitum.
All procedures were performed according to the regulations of the Canadian Council for Animal Care
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and were approved by the Animal Care Committees of McGill University and the McGill University
Health Centre (animal protocol #2009-5656).
Wild type and Prdx6−/− male mice were fed with a base diet (control) or a base diet supplemented
with 0.3% mixed tocopherols (containing 60% γ-tocopherol) [24] and a 1.75 g of ascorbic acid/kg diet.
Both diets were produced by ResearchDiets (New Brunswick, NJ, USA). We fed male mice (6 weeks old)
(n = 8 per group) ad libitum either with the control diet or the treatment diet (Vit. Mix diet) for 43 days
(the period to produce a full cycle of spermatogenesis and epididymal maturation in the mouse). Then,
we mated these males with age-matched WT females (ratio, 1:1) and determined the reproductive
outcomes (the litter size, unsuccessful mating, the weight of the pups at birth and the pup mortality
rate) of three consecutive matings and the sperm quality (motility, lipid peroxidation, DNA oxidation
and tyrosine nitration) in males euthanized after the last mating. The males continuously received
the Vit,. Mix diet to assure high levels of vitamins until the end of the matings, the WT females were
caged overnight, and the presence of a vaginal plug was considered indicative of successful mating.
The number of matings, litter size and weight of the pups at weaning were recorded. At the end of the
experiment, the males were euthanized to harvest the testes and spermatozoa for experiments.
2.2. Tissue Collection and Preparation
Male mice fed with the control or Vit. Mix diets were euthanized and weighed, and the testes,
epididymes and spermatozoa were collected. Immediately after collection, both cauda epididymes
were placed in 300 µL of Biggers, Whitten and Wittingham (BWW) medium composed of 91.5 mM
NaCl, 4.6 mM KCl, 1.7 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3, 5.6 mM
D-glucose, 0.27 mM sodium pyruvate, 44 mM sodium lactate and 20 mM HEPES for 10 min at 37 ◦C
to let the sperm swim out. Then, the spermatozoa in the BWW medium were collected, aliquots
were used to determine the sperm motility, and the rest of the samples were stored at −80 ◦C until
further use.
2.3. Determination of Sperm Motility and Epididymal Maturation
We used a computer-assisted sperm analysis system (CASA) with the Sperm Vision HR software
version 1.01 (Minitube, Ingersoll, ON, Canada) to evaluate the total and progressive sperm motility.
A total of 200 spermatozoa were examined for each sample to determine the percentages of sperm total
and progressive motility. We determined the percentage of cytoplasmic droplet retention to evaluate
epididymal maturation, as performed previously [25].
2.4. Determination of Lipid Peroxidation
We determined the levels of lipid peroxidation in spermatozoa by flow cytometry using a BODIPY
581/591 C11 probe (Thermo Fisher Scientific, Toronto, ON, Canada) as previously described [17].
Sperm samples from Prdx6−/− and WT mice were incubated with 5 µM BODIPY 581/591 C11 in HEPES
balanced saline (HBS, pH 7.4) for 30 min at 37 ◦C in the dark. A sperm aliquot with 40 µM ferrous
sulphate (FeSO4) in HBS, incubated for 2 h at 37 ◦C, was used as the positive control. Ten thousand
or more spermatozoa were analyzed for each sample using a MACSQuant Analyzer flow cytometer
(Miltenyi Biotec, Inc., Auburn, CA, USA) equipped with an argon laser (488 nm) and 585/625 nm filter.
The levels of lipid peroxidation are expressed as the relative intensity of the green fluorescence/red +
green fluorescence.
2.5. Determination of DNA Oxidation
The levels of 8-hydroxy-2’-deoxyguanosine (8-OHdG) were determined by immunocytochemistry,
as we previously reported [16,25]. Frozen spermatozoa were centrifuged to remove the PBS, thawed at
37 ◦C, and resuspended in PBS supplemented with 40 µM DTT, 1 µM EDTA and 1% SDS and incubated
for 5 min at room temperature. Then, smears were prepared and allowed to air dry. Dried cells were
permeabilized with 100% methanol at−20◦C, rehydrated with PBS supplemented with 0.1% Triton X-100
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(PBS-T), and blocked with 5% horse serum in PBS-T for 30 min at room temperature. After washing
with PBS-T, slides were incubated overnight at 4 ◦C with an anti-8-OHdG antibody (catalog # SMC-155,
StressMarq Biosciences Inc, Victoria, BC, Canada) at a 1:100 dilution. Then, the cells were washed
and incubated with goat anti-mouse antibody conjugated with Alexa Fluor Pluss 555 (Thermo Fisher
Scientific, Toronto, ON, Canada) at a 1:2000 dilution. Positive controls were made by incubating
spermatozoa with 5 mM H2O2 and 1 MM FeSO4.7H2O in BWW medium [16,25]. The specificity of the
primary antibody was confirmed by incubating smears of the sperm samples with the primary antibody
previously incubated with 8-OHdG (Abcam Inc, Toronto, ON, Canada) at a concentration 1000 times
higher than that of the primary antibody for 1 h at 20 ◦C, as performed previously [26]. Fluorescent
signals were analyzed under an epifluorescence microscope (Zeiss Axiophot, Germany). All the images
were captured with a digital camera (Retiga1300, QImaging, Burnaby, BC, Canada) and digitized
with the Northern Eclipse digital imaging software, version 6.0 (Empix Imaging, Mississauga, ON,
Canada). The results are expressed as the percentages of spermatozoa with a positive signal. At least
200 spermatozoa were counted per sample.
2.6. Determination of Tyrosine Nitration in Spermatozoa
We determined the levels of tyrosine nitration in spermatozoa from WT and Prdx6−/− males
fed with the control and Vit. Mix diets by immunocytochemistry, as previously performed,
with modifications [27]. After thawing, spermatozoa were smeared onto slides and allowed to
dry. Then, the cells were permeabilized with 100% methanol at −20 ◦C, rehydrated with PBS-T and
blocked with 5% goat serum for 30 min at room temperature. The sperm smears were washed again
with PBS-T and incubated overnight at 4 ◦C with the anti-nitro-tyrosine antibody (catalog # ab61392,
Abcam Inc, Toronto, ON, Canada) at a 1:100 dilution. Fluorescent signals were analyzed under an
epifluorescence microscope (Zeiss Axiophot, Germany). All the images were captured with a digital
camera (Retiga1300, QImaging, Burnaby, BC, Canada) with the same time exposure and digitized
with the Northern Eclipse digital imaging software, version 6.0 (Empix Imaging, Mississauga, ON,
Canada). The results are expressed as the percentages of spermatozoa with positive signals and as the
relative fluorescence intensity (RFI). To determine the RFI, digitized grayscale pictures were analyzed
with the Image J software V1.42q (National Institutes of Health, Bethesda, MD, USA). The mean gray
value of the background was subtracted from the values measured in the spermatozoa. The results are
expressed as relative units of RFI. At least 200 spermatozoa were counted per sample.
2.7. Statistical Analysis
All the results are presented as mean ± SEM, except for those in Figures 1 and 2, where the
medians are included in the dot plot graphs. The normality of the data and homogeneity of variances
were determined with the Shapiro–Wilk and Bartlett tests, respectively. We used the two-way ANOVA
and Bonferroni tests (to assess changes due to genotype and diet) and chi-square tests as appropriate
using GraphPad Prism 5 (GraphPad Software, Inc., San Diego, CA, USA) to determine statistical
differences among groups.
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Figure 1. Number of pups sired by wild type (WT) or Prdx6−/− males fed with control or Vit. Mix diets.
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Each circle or triangle corresponds to one litter from WT or Prdx6−/− males, respectively. Open symbols
correspond to males fed with the control diet, and black symbols correspond to males fed with the Vit.
Mix diet. A horizontal red line represents the median of each group. * p ≤ 0.05; *** p ≤ 0.001, two-way
ANOVA and Tukey tests.
















Control  27.9 ± 0.1  0.68 ± 0.01  0.27 ± 0.01  0% (0/24) 
Vit. Mix  28.1 ± 0.2  0.7 ± 0.021  0.28 ± 0.02  0% (0/24) 
Prdx6‐/‐ 
Control  27.7 ± 0.4  0.73 ± 0.02  0.28 ± 0.01  41.6% (10/24) * 











































Figure 2. Pup weight at 24 h after birth. Each circle or triangle corresponds to one litter from WT or
Prdx6−/− males, respectively. Open symbols correspond to males fed with the control diet, and black
symbols correspond to males fed with the Vit. Mix diet. The mjedian of each group is represented by a
horizontal red line. # means smaller than all the other groups (p ≤ 0.05, two-way ANOVA and Tukey
tests).
3. Results
3.1. Prdx6−/− Males Supplemented with the Vit. Mix Diet Have Similar Reproductive Outcomes to Wild
Type Mice
Prdx6−/− male mice fed with the Vit. Mix diet showed similar body, testis and epididymis weights
but produced a lower percentage of non-fertile matings than the Prdx6−/− males fed with the control
diet (Table 1). The Prdx6−/− male mice fed with the Vit. Mix diet produced higher numbers of pups
than the Prdx6−/− males fed with the control diet, similar number to that produced by the WT mice
(fed with either of the two diets) (Figure 1). Moreover, there were no significant differences in the
percentages of non-fertile matings observed in the Prdx6−/− mice fed with the Vit. Mix diet and the
WT mice (fed with the control or the supplemented diet). When we consider only the fertile matings,
the litter size was affected by the genotype but not by the diet.















Control 27.9 ± 0.1 0.68 ± 0.01 0.27 ± 0.01 0% (0/24)
Vit. Mix 28.1 ± 0.2 0.7 ± 0.021 0.28 ± 0.02 0% (0/24)
Prdx6−/−
Control 27.7 ± 0.4 0.73 ± 0.02 0.28 ± 0.01 41.6% (10/24) *
Vit. Mix 25.3 ± 0.3 0.67 ± 0.03 0.26 ± 0.01 12.5% (3/24)
* Means significantly higher than all others (Chi-Square, p ≤ 0.05).
We observed that the pups sired by the Prdx6−/− males fed with the control diet were significantly
smaller than those sired by the males of the other three groups (Figure 2). The mortality rates at
weaning time (21 days) were the lowest in the pups sired by the Prdx6−/− males fed with the Vit.
Mix diet. Interestingly, the supplementation with the Vit. Mix diet prevented the death of pups,
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and pups sired by the Prdx6−/− males fed the supplemented diet showed no significant differences in
mortality rates from WT controls (Figure 3).
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Prdx6 -/-WT
Control Vit.Mix Control Vit.Mix
Prdx6 -/-WT
Control Vit.Mix Control Vit.Mix
Figure 3. Mortality of pu s ired b T or Prdx6−/− males fed with control (open bars) and Vit.
Mix (black bars) diets, respectively. *** p ≤ 0.001, two-way NOVA and Tukey tests.
3.2. Vit. Mix Diet Improved Sperm Quality in Pr −/− Male Mice
Spermatozoa recovered from Prdx6−/− mice fed with the Vit. Mix diet showed higher total motility
than those from those fed with control diet, with values similar to those obtained for the WT mice
fed with either diet (Figure 4a). Progressive motility in the Prdx6−/− mice was lower than that in the
WT controls, but the Vit. Mix diet partially and significantly restored the progressive motility of the
Prdx6−/− mice compared to the con rol diet (Figure 4b). Th percentage of cyt plasmic droplet retention,
an indicator of immature spermatozoa and thus impaired epididymal maturatio , was significantly
lower in those mice fed with the Vit. Mix diet than in the controls, with no significant differences from
the WT controls (Figure 4c).
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Control Vit.Mix Control Vit.Mix
Prdx6 -/-WT
Control Vit.Mix Control Vit.Mix
Prdx6 -/-WT
Control Vit.Mix Control Vit.Mix
Figure 4. Motility and epi idymal maturation of s r tozoa fro WT or Prdx6−/− males fed with the
control ( pen bars) and Vit. Mix (black bars) , respectively. Total (A) and progressive (B) motility
and (C) cytoplasmic droplet retention, a marker of i mature spermatozoa. * p ≤ 0.05; *** p ≤ 0.001,
two-way ANOVA and Tukey tests.
3.3. Oxidative Stress in Spermatozoa Was Reduced by the Vit. Mix-Supplemented Diet
We determined the level of oxidative stress according to lipid peroxidation, DNA oxidation and
tyrosine nitration levels in spermatozoa from all groups. We found that the levels of lipid peroxidation
determined with the BODIPYC11 probe (Figure 5a) and DNA oxidation determined by the levels of
8-OGHdG (Figure 5b) were significantly lower in the spermatozoa from the Prdx6−/− mice fed with the
vitamin-supplemented diet than in the Prdx6−/− mice fed with the control diet. Moreover, there were
no significant differences in the levels of lipid peroxidation and DNA oxidation when comparing the
Prdx6−/− males fed with the Vit. Mix diet and WT controls.
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Figure 5. Lipid peroxidation (A) and DNA oxidation (B) in sper atozoa from WT or Prdx6−/− males fed
with control (open bars) and Vit. Mix (black bars) diets, respectively. (A) Lipid peroxidation measured
by flow cytometry using a BODIPYC11 fluorescent probe. (B) DNA oxidation determined by the
levels of 8-hydr x -2’-deox guanosine (8-OHdG) in spermatozoa according to immunocytochemistry.
** p ≤ 0.01; *** p ≤ 0.001, two-way ANOVA and Tukey tests.
Strong tyrosine nitration labelling was observed in the acrosome regions, midpieces and principal
pieces of spermatozoa from Prdx6−/− males fed with the control diet (Figure 6). The Prdx6−/− males fed
with the Vit. Mix nd the WT males had a similar patte n of ty osine nitration distribution in their
spermatozoa but t a significantly lesser extent. I dee , t e percentage f spermatozoa with positive
labelling and the fluorescence intensity observed were significantly higher in the spermatozoa from
the Prdx6−/− males fed with the control diet than in the other groups (Figure 6C,D).






































Genotype  <0.0001  0.018  <0.0001  <0.0001  <0.0001  0.0036  <0.0001  0.0002  0.0002  <0.0001 























































Prdx6 control    -/-





Prdx6 Vit.Mix    -/- Prdx6 control
(bright field)




    -/-
Figure 6. Tyrosine nitration in spermatozoa from WT or Prdx6−/− males fed with control (open bars)
and Vit. Mix (black bars) diets, respectively. Unspecific bindi g was ruled out by incubating Prdx6−/−
spermatozoa with secondary antibody alone (right panels). Percentages (A) and relative fluorescence
intensity (B) were determined by immunocytochemistry, and analysis of the fluorescence was performed
using the ImageJ software. # means higher than all the other groups. p ≤ 0.001, two-way ANOVA and
Tukey tests.
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Despite the primary effects of the genotype already observed and of the treatment, we observed
interactions between the genotype and the type of diet in all the parameters studied except for the
sperm motility and number of pups, indicating that infertile males with significant damage due to
oxidative stress and tyrosine nitration in their sperm benefit from the antioxidant treatment (Table 2).
In the case of the number of pups, the p value of 0.06 indicates the existence of a trend of interaction.






















Genotype <0.0001 0.018 <0.0001 <0.0001 <0.0001 0.0036 <0.0001 0.0002 0.0002 <0.0001
Diet 0.04 0.0009 0.0022 <0.0001 0.0002 <0.0001 <0.0001 0.0009 0.0009 <0.0001
Genotype
x diet 0.06 0.027 0.002 0.19 0.86 <0.0001 <0.0001 0.0023 0.006 <0.0001
4. Discussion
Oxidative stress has been identified as a culprit in 25–87% of male infertility cases [9]. However,
the benefits of antioxidant therapy for treating male infertility are still controversial. For more than a
decade, a series of systematic reviews have concluded that there are insufficient quality data to indicate
the benefit of using antioxidant therapy in infertile men to improve live birth rates and pregnancy
rates [9,28,29]. One of the causes of this low-quality evidence for beneficial effects is the inappropriate
selection of male participants. In most, if not all, randomized-controlled studies, including those in
these reviews, the selection of patients did not include the assessment of whether oxidative stress was
present in the semen. Thus, in some cases of male infertility, antioxidant therapy will not be beneficial
because the causes of infertility are not associated with oxidative stress. Although the evaluation
of oxidative stress markers seems obvious based on the high percentage of infertile men that have
oxidative stress in the semen [7–9], the practicality of including assays for the evaluation of ROS,
antioxidants and oxidative stress markers is challenging, since these assays are difficult to implement
widely at fertility clinics.
Prdx6−/− males are subfertile, and their spermatozoa are highly sensitive to oxidative stress [16].
Moreover, Prdx6−/− spermatozoa failed to produce viable embryos after in vitro fertilization [17].
The high levels of lipid peroxidation, and oxidation of proteins and DNA, along with low motility and
an incapacity to fertilize oocytes in vitro, are abnormal outcomes that are frequently found in infertile
men. Previously, we reported that PRDX6 is present in low amounts in spermatozoa from idiopathic
infertile men [11]. Furthermore, PRDX6 was highly thiol-oxidized and, therefore, inactive in the sperm
of these patients.
In this study, we used the Prdx6−/− mouse model to determine whether supplementation with
a novel combination of a γ-tocopherol-rich mixture of tocopherols and ascorbic acid could restore
fertility. The combination of vitamins used in this study successfully restored fertility in Prdx6−/−
males, since these males sired a higher number of pups with higher weights at birth and a lower
mortality rate than those pups sired by Prdx6−/−males fed with the control diet (Figures 1–3). These data
indicate that supplementation using an antioxidant formulation enriched with γ-tocopherol is safe,
producing healthy offspring. At a cellular level, the supplementation with the vitamin mix improves
the sperm quality of Prdx6−/− males. Indeed, a higher percentage of motility and lower levels of DNA
oxidation and tyrosine nitration were observed in spermatozoa from those Prdx6−/− males fed with the
supplemented diet than in those from those fed with the control diet.
The paternal genome’s integrity is essential to ensure healthy embryo development. Even when
spermatozoa contain significant DNA damage, they can fertilize oocytes, but embryo development is
severely affected [30]. We observed that in infertile men with varicocele or idiopathic infertility with
high levels of lipid peroxidation in the seminal plasma and spermatozoa, the amount of DNA damage
depends on the level of thiol-oxidized PRDX6 in their spermatozoa [11]. The thiol oxidation in PRDX6
promotes enzymatic inactivation and, therefore, the incapacity of PRDX6 to scavenge ROS. The lack
of PRDX6 generates high levels of DNA fragmentation and oxidation in mouse spermatozoa [16].
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The inhibition of PRDX6 peroxidase’s and iPLA2 activities promotes a dose-dependent decrease in
sperm viability associated with an increase in DNA oxidation [13]. Thus, the absence or inactivation of
PRDX6 is a plausible cause of sperm DNA damage in infertile men.
The peroxidation of the lipids in the sperm plasma membrane is associated with low motility and
infertility. PRDX6 iPLA2 activity is involved in the repair of peroxidized membranes [31]. Prdx6−/−
spermatozoa display higher levels of lipid peroxidation than WT controls, and WT spermatozoa
incubated with MJ33 have similarly high levels as those from the knockout mice, indicating that PRDX6
iPLA2 activity is necessary to protect the sperm plasma membrane against oxidative stress and allow
normal sperm motility [17,25]. Human spermatozoa also require PRDX6 iPLA2 to maintain low levels
of lipid peroxidation and assure sperm motility viability and fertilization ability [13,32].
Along with the iPLA2 activity, PRDX6 displayed peroxidase activity that is important for the
antioxidant defenses in the cell. The inhibition of PRDX6 peroxidase activity is associated with an
increase in the endogenous production of ONOO− upon treating healthy human spermatozoa with a
NO• donor (DA-NONOate) and an inhibitor of complex III of the mitochondrial electron transport
chain (antimycin A) [13]. Moreover, the DA-NONOate treatment was sufficient to increase the levels
of tyrosine nitration in human spermatozoa [27]. High levels of tyrosine nitration were observed in
spermatozoa from asthenozoospermic infertile men [33,34]. These previous findings and our present
results (Figure 6) suggest that tyrosine nitration is associated with impairment of sperm motility and
that PRDX6 peroxidase activity is the primary scavenger of ONOO− and, by maintaining low levels of
this ROS, assures normal sperm motility [13,27,33,34].
Noteworthily, peroxynitrite can induce the formation of lipid hydroperoxides in an iron-free
fashion [15]. The inhibition of PRDX6’s peroxidase activity produces an increase in endogenous
ONOO− and 4-HNE in human spermatozoa [13]. Moreover, the mitochondrial superoxide production
and loss of mitochondrial membrane potential depend on the level of 4-HNE [13,35]. These findings
indicate that ONOO— participates in the production of lipid peroxidation in human spermatozoa.
Although theγ-tocopherol form is a powerful antioxidant, it has been unexplored as an antioxidant
treatment for male infertility. Low levels of γ-tocopherol but not of α-tocopherol have been reported in
semen from infertile men with varicocele [36]. Low levels of these tocopherols were found in the blood
and seminal plasma of a population of infertile patients comprising men with asthenozoospermia,
asthenoteratozoospermia and oligoasthenozoospermia [37]. These studies are the first to demonstrate
the associations of low levels of γ-tocopherol with low motility or varicocele in infertile patients and
support our suggestion of treating male infertility with a combination of tocopherols enriched with
γ-tocopherol and ascorbic acid. Indeed, the supplementation of the diet fed to the Prdx6−/− males
with the Vit. Mix resulted in better reproductive outcomes than those seen in the Prdx6−/− males fed
with the control diet. This improvement was reflected not only by the increased number of healthy
pups produced (Figures 1–3) but also by better sperm quality, as indicated by the high sperm motility
(Figure 4) and low levels of lipid peroxidation, DNA oxidation and tyrosine nitration (Figures 5 and 6)
observed in the Prdx6−/− male mice that received the vitamin supplement.
Tocopherols (the active form of vitamin E) scavenge ROS and are converted into tocopheryl
radicals. Then, ascorbic acid converts the tocopheryl radicals to tocopherols for the re-cycling of
vitamin E [19]. As mentioned above, PRDX6 peroxidase activity is the unique scavenger of ONOO–
in human spermatozoa [13]. Although both α- and γ-tocopherol can scavenge H2O2 and organic
peroxides, γ-tocopherol is a more efficient scavenger of ONOO– and of lipophilic electrophiles that
generate lipid peroxidation than α-tocopherol [15,20,21], the most commonly used vitamin E form in
antioxidant supplement preparations. This efficiency in removing ONOO– is essential for protecting
the spermatozoon against lipid peroxidation and preventing the formation of 4-hydroxynonenal
(4-HNE), a toxic by-product of the peroxidation of lipids. This is important because 4-HNE can form
protein and DNA adducts, inactivating enzymes and promoting mutations in the paternal genome,
respectively [14,38].
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As mentioned above, lipid peroxidation impairs sperm motility [39,40], and its product, 4-HNE,
inactivates the enzyme succinate dehydrogenase in sperm [35]. The inactivation of this enzyme
promotes increased mitochondrial levels of superoxide anion, which leads to a reduction in motility
and the promotion of apoptosis-like changes in human spermatozoa. Since ONOO− promotes lipid
peroxidation [15], treatment with an antioxidant therapy rich in γ-tocopherol may restore fertility in
those men with significant levels of tyrosine nitration in their semen that are unable to father a child.
Further studies should be done to determine whether an antioxidant supplement rich in γ-tocopherol
will be beneficial for treating infertility in men.
5. Conclusions
In conclusion, our study using the Prdx6−/− model is a proof of concept that a supplement
containing a γ-tocopherol-enriched tocopherol mixture and ascorbic acid supplement are useful in
restoring fertility in this laboratory model. Indeed, infertile men with a deficiency in PRDX6 peroxidase
activity (or the PRDX6 protein) in their spermatozoa are at higher risk from the damage caused by
ONOO−-induced lipid peroxidation [15], even if they take α-tocopherol supplements. It is important to
highlight that without an appropriate strategy to identify idiopathic infertile men with oxidative stress
in their semen, any antioxidant therapy implemented will probably fail, a situation that is reflected
in the comprehensive reviews published in the last decade [9,28,29]. With such diagnostic tools that
can easily be incorporated into the clinical evaluation of the infertile patient, it is possible to design
randomized controlled trials with a large number of subjects, where the inclusion criteria include
evidence of ongoing oxidative stress. These studies will confirm whether antioxidant therapy is useful
for the treatment of cases of idiopathic infertility when high levels of ROS are the cause of the disease.
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